Bausch + Lomb looks set to benefit as more people get diagnosed and treated for dry eye, while new contact lens and surgery products help it grow beyond simple eye drops. The big question is whether those product launches and cost cuts can turn today’s weak profitability into steady profits fast enough to justify what the market already expects.Read more